| Print
Filana Therapeutics Inc (FLNA)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-relatedepilepsy.
Address
7801 N. Capital of Texas Highway
Suite 260
Austin
TX
USA
78731
Telephone
+1 512 501 2444
Forecast key dates
| Name | Key Date |
|---|---|
| Filana Therapeutics Inc Annual Report for 2026 | 2027-03-12T00:00:00 |
| Filana Therapeutics Inc Fourth Quarter Earnings Results for 2026 | 2027-03-12T00:00:00 |
| Cassava Sciences Inc Third Quarter Earnings Results for 2026 | 2026-11-12T00:00:00 |
| Cassava Sciences Inc Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
| Cassava Sciences Inc Annual General Meeting for 2026 | 2026-05-22T10:00:00 |
| Cassava Sciences Inc First Quarter Earnings Results for 2026 | 2026-05-08T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Filana Therapeutics Inc Fourth Quarter Earnings Results for 2025 | 2026-03-12T00:00:00 |
| Filana Therapeutics Inc Annual Report for 2025 | 2026-03-12T00:00:00 |
| Cassava Sciences Inc Third Quarter Earnings Results for 2025 | 2025-11-12T00:00:00 |
| H.C. Wainwright 27(th) Annual Global Investment Conference | 2025-09-08T17:00:00 |
| Cassava Sciences Inc Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
| Cassava Sciences Inc Annual General Meeting for 2025 | 2025-05-23T10:00:00 |
| Cassava Sciences Inc First Quarter Earnings Results for 2025 | 2025-05-08T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.